Design Therapeutics, Inc. | ||||
NMS : DSGN || Location: United States | ||||
$4.01+0.1 (+2.56%) |
0.13 M | 3.84 - 4.03 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 2.142 M |
Feb. 29, 2024 | 2.851 M |
Feb. 15, 2024 | 2.821 M |
Jan. 31, 2024 | 2.426 M |
Jan. 12, 2024 | 2.514 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
12/31/2023 | -0.32 | -0.21 | 33.52% |
09/30/2023 | -0.42 | -0.28 | 32.81% |
06/30/2023 | -0.41 | -0.36 | 11.22% |
03/31/2023 | -0.37 | -0.35 | 4.48% |
12/31/2022 | -0.35 | -0.31 | 11.66% |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 56.494M | Shares Float | 24.141M |
Short Float | 2.142M | Market Cap | 220.89M |
Institution ownership | 56.81% | Insider ownership | 36.668% |
Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
Trailing EPS | -1.19 | Forward EPS | -1.36 |